- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Danish Pharmaceuticals & Biotech Strong Balance Sheet Stocks
U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
10 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GMABGenmab | kr.2,235.00 | -2.5% | -15.4% | kr.146.2b | kr.2,867.88 | PE50.9x | E28.1% | n/a | ||
| ALK BALK-Abelló | kr.2,778.00 | -5.3% | 11.3% | kr.30.6b | kr.3,473.75 | PE273.3x | E37.0% | 0% | ||
| CHEMMChemoMetec | kr.646.50 | -1.5% | 22.0% | kr.11.3b | n/a | PE127.3x | n/a | 0.2% | ||
| ZEALZealand Pharma | kr.131.60 | -8.6% | -42.6% | kr.5.7b | kr.249.80 | PS18.8x | E27.6% | n/a | ||
| LUNH. Lundbeck | kr.165.45 | 1.9% | -26.3% | kr.32.9b | kr.219.13 | PE17.6x | E24.3% | 1.5% | ||
| NOVO BNovo Nordisk | kr.631.30 | 1.1% | 42.0% | kr.1.4t | kr.673.26 | PE31.1x | E8.7% | 1.5% | ||
| BIOPORBioPorto | kr.2.43 | -6.5% | -62.6% | kr.650.6m | kr.5.00 | PS26x | E-8.0% | n/a | ||
| ORPHAOrphazyme | kr.14.31 | -9.3% | -83.1% | kr.500.2m | kr.13.00 | PS38x | E58.6% | n/a | ||
| BAVABavarian Nordic | kr.209.80 | -5.3% | -4.3% | kr.14.8b | kr.412.29 | PS9.3x | E52.7% | n/a | ||
| STENOStenocare | kr.13.20 | -3.7% | -33.7% | kr.150.6m | n/a | PS75.5x | n/a | n/a |
Page 1 of 1